Introduction
Amelotin (AMTN) is the one of the secretory calciumbinding phosphoprotein (SCPP) clusters, expressed at the maturation stage in ameloblasts and in the inner basal lamina of the junctional epithelium (JE) after tooth eruption (1) (2) (3) (4) . Mice overexpressing the AMTN gene have a thin and irregular enamel due to enamel hypomaturation (5) , whereas mice with AMTN gene deficiency also have hypomature enamel due to delayed expression of kallikrein-related peptidase 4 (KLK4) (6) . Moreover, it has been reported that AMTN promotes the mineralization of hydroxyapatite (7, 8) . These findings suggest that AMTN plays a critical role in enamel maturation during amelogenesis, although the role of AMTN in the JE has remained unclear.
The JE is able to regenerate and persist at the interface between the gingival epithelium and tooth surface even after temporary removal due to inflammation and periodontal surgery (9) . We have previously investigated AMTN gene expression in inflamed gingival tissues from patients with chronic periodontitis. Levels of AMTN mRNA were increased in inflamed gingival tissue and by proinflammatory cytokines in human gingival fibroblasts and gingival epithelium (10, 11) . Expression of both(FDC-SP) (12, 13) at the JE was more marked in mice infected with Porphyromonas gingivalis than in noninfected mice. However, the expression was subsequently decreased at the severe periodontitis stage associated with JE destruction (14) . Moreover, we have previously reported that AMTN gene expression was temporarily upregulated in the gingival epithelium upon induction of apoptosis by transforming growth factor beta1 (TGFβ1) via the Smad3 signaling pathway (15) . These previous findings suggest that AMTN might play a critical role in JE development and maintenance of its homeostasis. However, changes in AMTN gene expression during apoptosis in the gingiva remain to be investigated.
Several proapoptotic factors that translocate to the outer mitochondrial membrane and oligomerize following their activation, such as Bim (16) , Bik (17) , and Bax (18) , play an important regulatory role in apoptosis in the gingival epithelium by rendering the membrane permeable to cytochrome c (19) . Some studies have investigated the relationship between apoptosis and periodontitis. For example, Aggregatibacter actinomycetemcomitans, which can be detected in the periodontal pockets of patients with aggressive periodontitis, induces apoptosis of gingival epithelial cells associated with phosphorylation of Smad2 and inhibition of Bcl2 (20, 21) .
In the present study, to examine whether TGFβ1-induced AMTN gene expression is inhibited during the progression of apoptosis in mouse gingival epithelial cells, we examined the relationship between overexpression of Bax and changes in AMTN gene expression, and the role of Smad3.
Materials and Methods
Reagents SFM-101 was purchased from Nissui (Tokyo, Japan). Fetal calf serum (FCS), penicillin, streptomycin, Lipofectamine 2000 and TrypLE Express were obtained from Invitrogen (Carlsbad, CA, USA). The pCMV5 control vector was purchased from Promega Co. (Madison, WI, USA). Recombinant human TGFβ1 was purchased from R&D Systems, Inc. (240-B-010, Minneapolis, MN, USA). Epidermal growth factor (EGF), phenylmethylsulfonyl fluoride (PMSF, serine protease inhibitor) and BAX Inhibiting Peptide V5 (BIPV5; B1436) were purchased from Sigma-Aldrich Japan (Tokyo, Japan). Complete protease inhibitor cocktail was from Roche Diagnostics (Tokyo, Japan). An apoptosis in situ detection kit was purchased from Wako (Osaka, Japan). Smad3 (MGC Mouse Smad3 cDNA, clone Id: 30432720) and pCMV-SPORT6.0 Bax (MGC Mouse Bax cDNA, clone Id: 6489475) were purchased from Thermo Fisher Scientific Biosciences Corp. (Lafayette, CO, USA and Yokohama, Japan). Isogen II was purchased from Nippongene (Tokyo, Japan). EXScript RT reagent kit, SYBR Premix Ex Taq and ApopLadder Ex were purchased from TaKaRa (Tokyo, Japan). KAPA TaqTM Extra HotStart was purchased from KAPA Biosystems (Boston, MA, USA).
Cell culture
The mouse-derived gingival epithelial cell line RCB1709; GE1 was purchased from RIKEN BRC (Tsukuba, Japan) (22) and cultured at 33ºC in 5% CO 2 and 95% air in SFM-101 containing 1% FCS, 10 ng/mL EGF, 1% penicillin and streptomycin. Cells were grown to confluence in 60-mm tissue culture dishes, and media were then changed to no-serum SFM-101 media for 12 h before treatment with recombinant human TGFβ1 (10 ng/mL). GE1 cells were then incubated in this medium with or without TGFβ1 (10 ng/mL) for various time intervals or for 24 h. Bax and Smad3 expression vectors at concentrations of 2, 4, and 6 μg/mL in the medium were used to examine dose-dependent overexpression of Bax (pCMV-SPORT6.0 Bax) and Smad3 (pCMV-SPORT6.0 Smad3). Forty-eight hours after plating to 60-mm dishes, cells at approximately 50-70% confluence were transfected using Lipofectamine 2000. The pCMV5 vector was used as a control.
Real-time PCR
Total RNAs were isolated from GE1 cells using Isogen II. The levels of mRNAs for AMTN, Smad3 and Bax were then analyzed relative to that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a control. Total RNA was used as a template for cDNA synthesis using the ExScript RT reagent kit. Quantitative real-time PCR was performed using the following primer sets: mouse AMTN (NM_027793.1) Forward, 5'-CTGT-CAACCAGGGAACCACT-3'; mouse AMTN Reverse, 5'-CGACCCGTCCTTTGAATTTCT-3'; mouse Smad3 (NM_016769.4) Forward, 5'-AGGGGCTCCC-TCACGTTATC-3'; mouse Smad3 Reverse, 5'-CATGGCCCGTAATTCATGGTG-3'; mouse Bax (NM_007527.3) Forward, 5'-CCGGCGAATTGGA-GATGAACTG-3'; mouse Bax Reverse, 5'-AGCTGC-CACCCGGAAGAAGACCT-3' and mouse GAPDH (NM_008084.3) Forward, 5'-TGAAGGGGTGGTT-GATGG-3'; mouse GAPDH Reverse, 5'-AAATG-GTGAAGGTCGGTGTG-3'. SYBR Premix Ex Taq (TaKaRa) was employed in a TP800 thermal cycler dice real time system (TaKaRa). The amplification reactions were performed as described previous (15) .
Western blot analysis
For Western blot analyses, cytosol and nuclear extracts were prepared as described previously (23) . Exponentially growing GE1 cells were transfected with the Bax expression plasmid (2 μg and 6 μg). Forty-eight hours after plating to 100-mm dishes, cells at approximately 50-70% confluence were transfected using Lipofectamine 2000. To confirm the overexpression of Bax protein, we used cytosol from GE1 cells.
The cytosol and nuclear extract from GE1 cells were separated by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to membranes for 90 min, then incubated overnight with anti-AMTN (1:500; Dr. Bernhard Ganss (15) , anti-Bax (1:1,000; ab7977, Abcam, Tokyo, Japan), anti-Smad3 (1:3,000; ab28379, Abcam), anti-phosphorylated Smad3 (pSmad3, phospho S423 + S425, 1:2,000; ab52903, Abcam), anti-Cdk2 (1:1,000; sc163, Santa Cruz Biotechnology, Dallas, TX, USA) and anti-β-actin antibodies (1:1,000; sc1616, Santa Cruz Biotechnology). Antirabbit IgG (1:100,000; normal rabbit IgG, sc-2027, Santa Cruz Biotechnology) and anti-goat IgG (1:5,000; HRP-conjugate, 12-348, Merc Millipore, Tokyo, Japan) antibodies were used as the secondary antibodies. Clarity Western ECL Substrate (170-5061, BIO-RAD, Tokyo, Japan) was used for detection of immunoreactivities.
Apoptosis analysis
To evaluate apoptosis in situ in terms of Bax overexpression, TUNEL staining was carried out using an Apoptosis in situ Detection Kit (Wako). GE1 cells were plated on culture slides (Falcon CultureSlides, Corning BioCoat, Tokyo, Japan) and transfected with the Bax expression vector (2, 4, and 6 μg/mL) in SFM-101 medium. Two days after transfection, the cells were deprived of serum for 24 h. They were then fixed with 4% paraformaldehyde (PFA) for 10 min at room temperature prior to the procedure, which was performed in accordance with the manufacturer's protocol.
Immunocytochemistry (ICC) analysis
To analyze the protein expression levels of Smad3 and Bax in GE1 cells, ICC was carried out. TGFβ1 (10 ng/ mL) in no-serum SFM-101 medium was used to stimulate GE1 cells on culture slides (Falcon CultureSlides, Corning BioCoat) for 12, 24, 48, 72, and 96 h. The stimulated cells were fixed with 4% PFA for 10 min at room temperature. The fixed cells were then rinsed with PBS (−) twice for 5 min, and then with washing buffer (1x TBS solution), and blocked for 10 min. Anti-Bax antibody and anti-Smad3 antibody were used as the primary antibodies, diluted with buffer (50 mM Tris-HCl pH7.2, 1.0% BSA) consistent with the procedure for Western blot analysis. The primary antibodies were applied for 1 h at room temperature, followed by incubation with a secondary antibody for 30 min for immunocytochemical analysis (EnVision + System HRP Labeled Polymer Anti-Rabbit, DAKO, Tokyo, Japan) for signal detection. Following color development with diaminobenzidine, the cultured cells were counterstained with methyl green (S1962, DAKO) for 5 min and mounted. Images were captured with an OLYMPUS DP71 digital camera mounted on an OLYMPUS BX51 microscope (OLYMPUS, Tokyo, Japan).
Transient transfection assays
GE1 cells at 50-70% confluence were also used for transfection assays at 48 h after plating using Lipofectamine 2000 reagent. The transfection mixture included 2 μg of each respective luciferase (LUC) construct (−1651AMTN, −1651~+65), 1 μg β-Gal vector as an internal control, the pCMV5 vector or the Bax overexpression plasmid (6 μg/60 mm dish). Two days after transfection, the cells were deprived of FCS and EGF for 12 h, and TGFβ1 (10 ng/mL) in no-serum SFM-101 medium (10 ng/mL) was added for 24 h prior to harvesting. Luciferase activities were measured according to the supplier's protocol (PicaGene, Toyo Inki, Tokyo, Japan) using a luminescence reader (Acuu FLEX Lumi 400; Aloka, Tokyo, Japan).
Chromatin immunoprecipitation (ChIP) assays
To investigate whether Bax overexpression abrogated the Smad3-specific binding to SBEs in vivo in the mouse AMTN gene promoter, ChIP assays were performed using GE1 cells. Bax (2 or 6 μg) overexpression plasmids were used for transfection of 50-70% confluent GE1 cells with Lipofectamine 2000. The pCMV5 vector was used as a control. Prior to collection, the cells were fixed with 160 μl formaldehyde for 10 min to cross-link the protein-DNA complexes. Extraction of DNA including SBEs was conducted as described previously (15) . Two micrograms of the rabbit polyclonal anti-Smad3 antibody (ab28379, Abcam) and the appropriate unconjugated normal rabbit anti-IgG antibody (sc-2027, Santa Cruz Biotechnology) were used for immunoprecipitation of protein-DNA complexes in each sample. The DNA purified by proteinase K and ethanol precipitation was subjected to PCR amplification (1 cycle, 95ºC for 3 min; amplification was performed for 35 cycles, denaturation at 95ºC for 15 s, annealing at 59 or 60ºC for 15 s, and extension at 72ºC for 1 min; the final extension was done at 72ºC for 1 min) for SBEs within the mouse AMTN promoter using primer sets (15) . For the PCR procedure, KAPA TaqTM Extra HotStart was utilized.
Statistical analysis
Triplicate samples for real-time PCR were analyzed for each experiment and replicated to ensure consistency of the responses to TGFβ1, and overexpression of Bax and Smad3. The significance of differences between the control and treatments was determined using multiple comparison calibration (Tukey-Kramer method) for realtime PCR and one-way analysis of variance (one-way ANOVA).
Results
We showed that TGFβ1-induced AMTN gene expression reduced gradually with time. The level of AMTN mRNA increased temporarily at 24 h of TGFβ1 treatment (10 ng/mL), and then decreased gradually at 48 and 72 h (Fig. 1a) . Similarly, AMTN expression was increased by TGFβ1 (10 ng/mL) and became maximal at 48 h of TGFβ1 treatment, before being greatly reduced at 72 h. Actin expression used as a control was not changed (Fig.  1b) . These results were in agreement with our previous data (15) .
We then confirmed changes in the expression of Smad3, which is a well-known transcriptional modulator activated by TGFβ1 (24, 25) . The level of Bax expression was also investigated during apoptosis induced by TGFβ1. The levels of Smad3 and Bax mRNA were increased by TGFβ1 (10 ng/mL) in a time-dependent manner, and persisted until at least 72 h of TGFβ1 treatment (Fig. 2a) . ICC showed that increases in Smad3 expression began at 24 h of TGFβ1 treatment (10 ng/mL) and that the Bax protein level also increased in parallel. These TGFβ1-induced increases in Smad3 and Bax expression paralleled the time-dependent change in their mRNA levels (Fig. 2b ).
We hypothesized that the level of AMTN expression would decrease as apoptosis progressed, and examined whether the effects of overexpression of Bax, a proapoptotic protein, would coincide with the progression of apoptosis. Dose-dependent overexpression of Bax induced apoptosis of GE1 cells, and positive cells detected by TUNEL staining were evident mainly at the time of Bax overexpression (4 and 6 μg) (Fig. 3a) . BIPV5 peptide, a permeable peptide, is known to play a role in suppression of apoptosis by binding to Bax in the cytosol (26, 27) . We utilized Bax Inhibiting Peptide V5 (BIPV5; B1436) to evaluate whether Bax overexpression-induced apoptosis was conducted appropriately without cytotoxicity of transfection. The apoptosis was induced by Bax overexpression (6 μg) in GE1 cells that had been incubated without BIPV5 peptide, and Bax-mediated cell death in GE1 cells was slightly decreased by incubation with BIPV5 peptide (200 μM) for 72 h. Subsequently, apoptotic cells overexpressing Bax were hardly detected when BIPV5 peptide (400 and 800 μM) was present. These results suggested that Bax overexpression specifically induced apoptosis in GE1 cells without cytotoxicity (Fig. 3b) . Levels of Bax mRNA and protein expression in the cytosol were confirmed by real-time PCR and Western blot analysis, respectively. Both were found to increase in parallel with Bax overexpression (Fig. 3c, d) .
We next investigated whether Bax expression suppressed the level of AMTN mRNA expression induced by TGFβ1. Treatment with TGFβ1 (10 ng/mL) for 24 h upregulated the expression of AMTN mRNA. Interestingly, dose-dependent overexpression of Bax inhibited the expression of TGFβ1-induced AMTN mRNA (Fig. 3e) . Transient transfection analyses were performed using chimeric constructs encompassing different regions of the mouse AMTN gene promoter ligated to a luciferase reporter gene transfected into the GE1 cells (15) . The transcriptional activities of the AMTN promoter constructs, -1651AMTN (−1651~+65) including SBEs, were increased by TGFβ1 (10 ng/ mL) for 24 h in agreement with a previous study (15) . Overexpression of Bax (6 μg) partially abrogated the transcriptional activities mediated by TGFβ1 (Fig. 3f) . These results suggested that Bax overexpression silenced the TGFβ1-induced transcriptional upregulation of the AMTN gene.
To examine the mechanism whereby TGFβ1-upregulated AMTN mRNA levels were prevented by Bax overexpression, we analyzed the relationship between the change in Smad3 protein expression and the overexpression of Bax, which mediated the binding of Smad3 to response elements in the mouse AMTN promoter.
Smad3 is well known to exist in both the nucleus and cytosol, and to translocate from the latter to the former by binding to Smad4 (28) . Smad3 expression in the nucleus and cytosol was increased by treatment with TGFβ1 for 24 h, and Smad3 expression in the nucleus was also slightly increased by overexpression of Bax (2 and 6 μg) (Fig. 4a) . Phosphorylated Smad3 (pSmad3) expression was also increased by treatment with TGFβ1 for 24 h, and Bax overexpression did not influence the phosphorylation of Smad3. Bax expression was not detected in the nucleus. Expression of Smad3 and Bax induced by TGFβ1 in the cytosol was slightly upregulated in the presence of Bax overexpression, compared with that in its absence. These findings suggested that Bax expression was not directly involved in down-regulation of Smad3 expression and phosphorylation of Smad3 in the nucleus. On the other hand, Bax expression induced expression of Smad3 protein in the nucleus and cytosol, although Bax reduced the effect of TGFβ1 stimulation on the upregulation of Smad3 and Bax (Fig. 4a) .
As we suspected that overexpression of Bax blocked the binding of Smad3 to SBEs in the AMTN gene promoter without any reduction of Smad3 expression in the nucleus ChIP assay analyses were performed using the primers designed in our previous study (15) . In that study we had found that SBE5, SBE6 and SBE7 actively responded to TGFβ1 treatment (15) . We confirmed the dose-dependent expression of Smad3 in the nucleus by Western blotting using a Smad3 overexpression vector (Fig. 4b) . Smad3 binding to these SBEs was increased by Smad3 overexpression, and totally inhibited by Bax overexpression (Fig. 4c) . Smad3 binding to the SBEs, including SBE3-8, was upregulated by TGFβ1 (10 ng/ mL) and became maximal at 24 h. Overexpression of 2 μg/mL Bax did not affect the binding of Smad3 to the SBEs, but Bax at 6 μg/mL completely inhibited SBE- Smad3 binding (Fig. 4d) .
These results demonstrated that AMTN mRNA levels induced by TGFβ1 via Smad3 binding to SBEs were gradually inhibited upon robust expression of Bax without any reduction of Smad3 expression during apoptosis (Fig. 5 ).
Discussion
In this study, we showed that AMTN mRNA expression that was temporarily induced by TGFβ1 treatment for short periods of time was down-regulated by TGFβ1-induced Bax expression or Bax overexpression in gingival epithelial cells. These results suggest the presence of a negative feedback mechanism during the progression of apoptosis involving indirect interaction between Smad3 and robust expression of Bax.
TGFβ1 possesses a wide range of biological functions, such as suppression of the proliferation of gingival epithelial cells (29, 30) , early embryogenesis (31) and hematopoiesis (32) , apoptosis of gingival epithelial cells, and formation of the junctional epithelium (33) . Apoptosis can occur through three major pathways: the mitochondrial pathway, the Fas cell surface receptor pathway, and endoplasmic reticulum stress (34) (35) (36) . Smad3, a downstream factor of TGF-β/Activin/Nodal signaling, promotes the expression of the apoptosisrelated proteins Bax, Cyt C and caspase 3, resulting in a higher Bax/Bcl-2 ratio. Bax, Bcl-2, and Cyt C are mainly associated with the mitochondrial pathway. Therefore, Smad3 overexpression might be expected to aggravate apoptosis. In fact, our previous study using TUNEL staining showed that Smad3 overexpression induced apoptosis of gingival epithelial cells (15) , and similarly, Bax overexpression appeared to induce apoptosis via an independent pathway involving Bax expression (Fig. 3a) . Thus, we demonstrated a modulatory link between the TGFβ1-Smad3 pathway and the Bax expression mitochondrial pathway.
Our results of real-time PCR showed that TGFβ1-induced AMTN mRNA levels were substantially reduced by Bax overexpression (Fig. 3e) . The robust Bax expression might have stronger effects on the progression of apoptosis than TGFβ1-induced Smad3, although the reaction might not be Smad3 pathway-specific. However, the apoptotic change shown by GE1 cells in response to Bax overexpression was entirely and dose-dependently inhibited by BIPV5 treatment, and therefore Bax overexpression could be a useful parameter for evaluation of Bax-induced apoptosis of GE1 cells (Fig. 3b ).
To clarify whether the level of AMTN mRNA was decreased by Bax expression consistent with the removal of Smad3 binding to SBEs in the AMTN gene promoter, we carried out a ChIP assay utilizing Bax overexpression with/without TGFβ1 treatment for 24 and 48 h. Bax expression reduced the level of AMTN mRNA and Smad3 binding to SBEs (Figs. 3e; 4c, d ). As Bax is not a transcription factor and is not expressed in the nucleus, it would not bind directly to Smad3 in the nucleus and SBEs. Furthermore, Bax overexpression did not exert a direct negative effect on Smad3 binding to SBEs for regulation of the AMTN gene. The mechanism of physical interaction between Smad3 and Bax is unknown, although it has been reported that Smad3 overexpression promotes the expression of apoptosis-related Bax mRNA in hepatocytes (37). As we found that Bax expression induced Smad3 expression in the nucleus and cytosol (Fig. 4a) , it is suggested that Smad3 and Bax show symmetrical interaction in gingival epithelial cells while the normal nuclear import machinery of Smad3 is maintained. Although a previous study has reported a relationship between the growth of gingival fibroblasts and epithelial cells in smoking-related apoptosis, the components of JE and transcription factors were not addressed (38) . On the other hand, an increase of p-Smad2/3 nuclear translocation has been reported to induce periostin expression in gingival overgrowth (39) . Furthermore, nicotine, one of the environmental risks factors for periodontitis, induces apoptosis through generation of ROS and the caspase3 (Casp3)-dependent pathway in HGFs (40) , and cigarette smoke condensate has been shown to reduce the growth of HGFs by modulation of Bax, p53 and Casp3 expression (38) . These reports suggest the clinical importance of understanding the mechanism of JE homeostasis and resistance to periodontal pathogens and risk factors for periodontitis. Although the gingival epithelial layer constitutes a barrier at the interface between the tooth surface and gingival tissue, the molecular details of its interaction with several apoptosis factors remain poorly understood. However, the available data support the contention that Smad3 plays a critical role in the proliferation of gingival epithelium and fibroblasts.
Receptor-regulated Smad, including Smad3, can bind to SBEs at the β-hairpin structures preserved in the MN1 domain (41) . SBEs are present in several gene promoters, but not all of them are targeted by the Smad family. The direct binding of Smad to SBEs in the target gene promoter is relatively weak, and therefore formation of a stable Smad complex together with other transcription factors and co-activators is required for proper transcriptional regulation in the majority of Smad-targeted gene promoters, such as SP1 in the type I collagen gene (42) , AP1 in the collagenase 3 gene (43) , and TFE3 in the Smad7 gene (44) . In addition, the TGFβ1-targeted gene varies according to cell type. For example, expression of Type I collagen is specifically induced by TGFβ1 in fibroblasts and osteoblasts, but not in hemocytoblasts and epithelial cells (30, 33, 42) . However, the function of these transcription factors in extracellular matrix genes is likely to be driven by the formation of complexes with Smad3, and not suppression of their target gene transcription. These findings raise the possibility that these transcription factors affect the downregulation of AMTN gene expression by Smad3 and Bax interaction. In fact, with regard to AP1, no immunoprecipitation reaction of Smad3 was demonstrated in the mouse AMTN gene promoter, including the AP1 consensus response elements (15) .
Taken together, these results suggest that Bax expression-mediated inhibition of AMTN gene expression is mediated by removal of Smad3 from SBEs in the AMTN gene promoter. Our data clearly demonstrate the mechanism of Smad3 removal from SBEs, and thereby Smad3 plays a direct role in stable regulation of AMTN gene expression during the entire process of apoptosis in the gingival epithelium. Furthermore, these negative responses are context-specific in the presence of Bax.
